empower pharmacy eli lilly

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound,

Houston Public Media · 1d

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

Health News Florida · 22h

Eli Lilly sues companies selling alternative versions of its weight loss drug

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.

Fierce Pharma12h

Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. | The FDA has ...

GlobalData on MSN1d

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

NBC Los Angeles24d

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly is suing two pharmacies for compounding ... Lilly alleges the two companies — Strive Pharmacy and Empower Pharmacy — are falsely marketing their products as personalized versions ...

What is a compounding pharmacy? A look at the safety and affordability of Big Pharma's new rival

Compounding pharmacies use active pharmaceutical ingredients – the part of the medication that produces therapeutic effects – ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results